Navigation Links
Perrigo Announces Launch of Generic Version of Elestat®
Date:11/1/2011

ALLEGAN, Mich., Nov. 1, 2011 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that its partner, PharmaForce/Luitpold Pharmaceuticals, received final approval for Epinastine HCl ophthalmic solution, 0.05%, a generic version of Elestat®. Perrigo will commence shipment of the product immediately.

Elestat® is a sterile ophthalmic solution containing epinastine that is indicated for the prevention of ocular itching associated with allergic conjunctivitis. Estimated annual brand sales for the product prior to generic market formation were $30 million, according to Wolters Kluwer data.

Perrigo's Chairman and CEO Joseph C. Papa stated, "Perrigo is excited to launch another new product in the ophthalmic category, as part of our extended topical strategy. This product is another example of Perrigo's commitment to expand our portfolio and bring new products to market. It further demonstrates our strategy to deliver quality affordable healthcare products."

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, and active pharmaceutical ingredients (API). The Company is the world's largest manufacturer of OTC pharmaceutical products and infant formulas, both for the store brand market. The Company's primary markets and locations of manufacturing and logistics operations are the United States, Israel, Mexico, the United Kingdom and Australia. Visit Perrigo on the Internet (http://www.perrigo.com).

Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or the Company's future financial performance and involve known and unknown risks, uncertainties
'/>"/>

SOURCE Perrigo Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Perrigo Company to Attend the 2011 Annual Meeting of the American College of Allergy, Asthma & Immunology
2. Perrigo Reports Record Quarterly Revenue and Adjusted Earnings and Raises Full Year Adjusted EPS Guidance
3. Perrigo Company Announces Quarterly Dividend
4. Perrigo Expands Infant Formula Distribution in China With Founder Group
5. Perrigo Company Will Release First Quarter Fiscal 2012 Results On October 27, 2011
6. Perrigo Company Confirms FDA Tentative Approval for Clobetasol Propionate Emulsion Foam
7. Perrigo to Host Analyst Day on October 5, 2011 at the TASE, Tel Aviv Stock Exchange in Tel Aviv, Israel
8. Perrigo to Host Analyst Day on September 27, 2011 at the NASDAQ MarketSite in Times Square
9. Perrigo Announces FDA Final Approval for Ketoconazole Foam, 2%
10. Perrigo Company Will Release Fourth Quarter Fiscal 2011 Results on August 16, 2011
11. Watson Enters into Agreement to Acquire Products Related to Perrigos Acquisition of Paddock Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... SAN ANTONIO , April 28, 2015 /PRNewswire/ ... that the U.S. Patent and Trademark Office has ... GenSpera,s intellectual property portfolio claiming numerous compositions for ... Prostate Specific Antigen (PSA).  GenSpera ... specific peptides with a powerful cytotoxin isolated from ...
(Date:4/28/2015)... 2015 /CNW/ - The group representing the living victims of ... a two-hour meeting with Health Canada officials in a ... Canada announced a $180 million support package for Thalidomide ... after the Health Canada announcement and five months after ... victims, the group representing Canada,s ...
(Date:4/28/2015)... April 28, 2015 Anteo Technologies is ... new tools developed with their patented Mix&Go™ Activation ... methods, helping to improve medical devices and in-vitro ... Increasingly complex multifactorial diagnosis of cancer and ... It is restricted to measure only a ...
Breaking Medicine Technology:GenSpera Granted New Patent for Prodrugs Activated by Prostate Specific Antigen 2Thalidomide Victims Gravely Concerned by Health Canada's Silence 2Faster Detection of Disease: Anteo is Transforming The Way Scientists Work with Luminex(R) xMAP(R) 2Faster Detection of Disease: Anteo is Transforming The Way Scientists Work with Luminex(R) xMAP(R) 3
... Md., May 23, 2011 The healthcare and computing ... the healthcare industry has been adopting new technologies allowing ... medical devices strive to meet these requirements of the ... (near field frequency) chips in medical devices for communication ...
... Olympus Biotech, an Olympus Corporation company, today ... of president of Olympus Biotech Corporation. In his new ... business and focus on expanding opportunities for the emerging ... member of the Olympus Biotech Board of Directors. ...
Cached Medicine Technology:Your Wireless Healthcare Provided By PulseOximetersPlus 2Olympus Biotech Names Oliver Burckhardt to President North America 2
(Date:4/28/2015)... New York (PRWEB) April 28, 2015 ... http://www.xareltolawsuit2015.com/ ) are moving forward nationwide, as courts ... convene conferences next month. According to court documents ... of Louisiana, the next status conference in the ... 13th at 9:00 a.m. C.S.T. (In Re: ...
(Date:4/28/2015)... San Fancisco, California (PRWEB) April 28, 2015 ... and Clear Skin Concierge have developed a new, ... and treatment for acne sufferers using their specialized ... allows residents anywhere in the state of California ... without the need to travel to a physical ...
(Date:4/28/2015)... Georgia State University’s School of Public Health ... partner with the school on efforts to improve policies ... produces more tobacco and has more smokers than any ... Control Partnership-Tobacco Free Cities, will focus on a group ... tobacco control efforts and where public health organizations are ...
(Date:4/28/2015)... MSA Executive Search , an ... today that it has been retained to lead a ... for The Queen's Health Systems (QHS) located ... President & CEO Arthur A. Ushijima, the Executive Vice ... for the Queen’s Medical Center Punchbowl and West O’ahu ...
(Date:4/28/2015)... Georgia Partnership for TeleHealth (GPT), ... in communities throughout Georgia, announces that four members of ... the American Telemedicine Association ’s ATA 2015 conference, ... CA. , GPT’s roster of conference speakers includes ... Loren Nix, Liaison; and board member Dr. Jean Summer. ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuits Move Forward Nationwide, with Scheduling of May Conferences in Federal, State Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, with Scheduling of May Conferences in Federal, State Litigations 3Health News:New Online Acne Treatment Service for California 2Health News:Georgia State Names Partner Cities For Tobacco Control Project 2Health News:The Queen’s Health Systems Retains MSA Executive Search to Recruit Executive Vice President & Chief Operating Officer 2Health News:Georgia Partnership for TeleHealth Team Selected to Present at ATA 2015 2
... risk of recurrence in those who delay it , THURSDAY, ... breast cancer surgery, the question of whether or not to ... research that suggests that the longer women wait, the greater ... the March 3 online edition of BMJ , are ...
... ... Susan G. Komen Race for the Cure® events across the country. , ... Collegedale, TN (Vocus) March 4, 2010 -- Sunbelt ® ... events across the country. , , , , ,“The Sunbelt employees who volunteered and participated in ...
... , ... ... ... ...
... ... most wanted gifts for UK mums this Mother,s Day , ... London, UK (PRWEB) March 4, 2010 -- Voucher codes website Savoo.co.uk ... Boots voucher codes travel and clothing are the top three most desired gifts by ...
... ... ... ... ...
... ... the creation of an online education series for treatment professionals. , ... Carlsbad, CA (PRWEB) ... has announced the creation of an online education series for treatment professionals., , ...
Cached Medicine News:Health News:Sunbelt Announces Renewed Commitment to Breast Cancer Awareness 2Health News:Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line 2Health News:Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line 3Health News:Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line 4Health News:Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line 5Health News:Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line 6Health News:Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line 7Health News:Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line 8Health News:Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line 9Health News:Voucher Site Savoo.co.uk Reveals What Mum's Really Want This Mother's Day 2Health News:State-of-the Art in Alzheimer's Research Featured at 25th Conference of Alzheimer's Disease International 2Health News:State-of-the Art in Alzheimer's Research Featured at 25th Conference of Alzheimer's Disease International 3Health News:State-of-the Art in Alzheimer's Research Featured at 25th Conference of Alzheimer's Disease International 4Health News:State-of-the Art in Alzheimer's Research Featured at 25th Conference of Alzheimer's Disease International 5Health News:State-of-the Art in Alzheimer's Research Featured at 25th Conference of Alzheimer's Disease International 6Health News:Montecatini Eating Disorders Program Announces 'Log In & Learn' Webinar Series for Treatment Professionals 2Health News:Montecatini Eating Disorders Program Announces 'Log In & Learn' Webinar Series for Treatment Professionals 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: